Syon Capital’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$505K Sell
6,458
-2,952
-31% -$238K 0.02% 622
2026
Q1
$815K Sell
9,410
-7,916
-46% -$758K 0.04% 373
2025
Q4
$1.66M Buy
17,326
+4,761
+38% +$462K 0.08% 171
2025
Q3
$1.2M Buy
12,565
+2,555
+26% +$235K 0.06% 217
2025
Q2
$873K Sell
10,010
-2,391
-19% -$203K 0.06% 238
2025
Q1
$1.11M Buy
12,401
+2,642
+27% +$236K 0.09% 166
2024
Q4
$780K Buy
9,759
+1,422
+17% +$123K 0.07% 193
2024
Q3
$751K Sell
8,337
-1,554
-16% -$131K 0.07% 214
2024
Q2
$779K Buy
9,891
+1,138
+13% +$93.3K 0.07% 191
2024
Q1
$763K Buy
8,753
+1,926
+28% +$164K 0.07% 200
2023
Q4
$562K Buy
+6,827
New +$520K 0.06% 232

Other funds holding MDT

Syon Capital's MDT Position: Q2 2026 in Review

Syon Capital reduced its Medtronic (MDT) stake by 31% in Q2 2026, selling an estimated $238K and leaving 6,458 shares worth $505K. The position accounts for 0.02% of the portfolio, ranked #622.

Syon Capital first reported a position in MDT in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.66M in Q4 2025. 2,141 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Syon Capital held 6,458 shares of Medtronic worth $505K as of Q2 2026.
  • Syon Capital sold 2,952 Medtronic shares in Q2 2026, an estimated $238K.
  • Medtronic made up 0.02% of Syon Capital's portfolio in Q2 2026, its #622 holding.
  • Syon Capital first reported a position in Medtronic in Q4 2023 and has held it in 11 quarters since.
  • Syon Capital's Medtronic position peaked at $1.66M in Q4 2025.
  • 2,141 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Syon Capital's 13F filing for Q2 2026, filed 14 Aug 2026.